Published in Atherosclerosis on April 01, 2002
Statin therapy and mortalitiy in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Neth Heart J (2004) 0.84
Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy. Hernia (2005) 0.82
Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes. Indian J Med Res (2013) 0.79
Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study. Thromb Res (2015) 0.76
Pleiotropic vasoprotective effects of statins: the chicken or the egg? Drug Des Devel Ther (2009) 0.75
Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med (2007) 18.78
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med (2005) 15.18
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA (2011) 8.24
Statins and cancer risk: a meta-analysis. JAMA (2006) 6.28
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet (2006) 5.67
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation (2004) 4.87
Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med (2006) 3.90
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Circulation (2011) 3.01
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS (2006) 2.98
Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation (2002) 2.97
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA (2004) 2.86
Effect of statins on skeletal muscle function. Circulation (2012) 2.54
Number and impact of published scholarly works by pharmacy practice faculty members at accredited US colleges and schools of pharmacy (2001-2003). Am J Pharm Educ (2007) 2.36
Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med (2011) 2.28
Differences in medical care and disease outcomes among black and white women with heart disease. Circulation (2003) 2.16
Impact of statin dosing intensity on transaminase and creatine kinase. Am J Med (2007) 2.15
SLC30A8 nonsynonymous variant is associated with recovery following exercise and skeletal muscle size and strength. Diabetes (2013) 2.05
Acute aortic dissection related to crack cocaine. Circulation (2002) 1.97
Variability in muscle size and strength gain after unilateral resistance training. Med Sci Sports Exerc (2005) 1.95
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur Heart J (2014) 1.88
Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis (2007) 1.87
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial. Lancet (2009) 1.87
ACE ID genotype and the muscle strength and size response to unilateral resistance training. Med Sci Sports Exerc (2006) 1.86
Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation (2012) 1.76
Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation (2004) 1.68
Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol (2003) 1.65
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med (2009) 1.62
ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol (1985) (2005) 1.57
Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg (2008) 1.55
In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. J Am Coll Cardiol (2006) 1.52
Postexercise hypotension differs between white and black women. Am Heart J (2003) 1.51
Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease. Am Heart J (2002) 1.49
Cardiac arrest in patients who smoke crack cocaine. Am J Cardiol (2007) 1.49
Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J Am Diet Assoc (2009) 1.44
A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg (2002) 1.43
Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol (2003) 1.42
Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction. Heart Rhythm (2007) 1.42
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis. Diabetes Res Clin Pract (2009) 1.42
The renal protective effects of angiotensin II receptor blockers in type 2 diabetes mellitus. Ann Pharmacother (2004) 1.41
Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med (2008) 1.41
Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review. Int J Clin Pract (2011) 1.41
Prasugrel: a critical comparison with clopidogrel. Pharmacotherapy (2009) 1.41
Reassessment of National Cholesterol Education Program Adult Treatment Panel-III guidelines: one year later. Am J Cardiol (2002) 1.39
Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacother (2007) 1.38
Effect of prior exercise on postprandial lipemia and markers of inflammation and endothelial activation in normal weight and overweight adolescent boys. Eur J Appl Physiol (2009) 1.36
Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens (2008) 1.35
Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract (2009) 1.34
The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care (2005) 1.22
A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design. Prev Cardiol (2010) 1.21
The endothelial microparticle response to a high fat meal is not attenuated by prior exercise. Eur J Appl Physiol (2009) 1.20
The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials. Curr Med Res Opin (2008) 1.18
Active commuting to school: how far is too far? Int J Behav Nutr Phys Act (2008) 1.17
Effect of cinnamon on glucose control and lipid parameters. Diabetes Care (2007) 1.17
The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med (2009) 1.15
Postoperative atrial fibrillation - what do we really know? Curr Vasc Pharmacol (2010) 1.14
Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation (2007) 1.10
Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin (2007) 1.09
Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes. Am J Cardiovasc Drugs (2009) 1.06
Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease. Am J Cardiol (2009) 1.04
Influence of acute exercise with and without carbohydrate replacement on postprandial lipid metabolism. J Appl Physiol (1985) (2008) 1.04
Alterations in osteopontin modify muscle size in females in both humans and mice. Med Sci Sports Exerc (2013) 1.03
The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail (2006) 1.02
The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. Atherosclerosis (2008) 1.01
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Alzheimers Dement (2008) 1.01
Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother (2008) 1.00
PPARalpha L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males. BMC Med Genet (2007) 0.99
Retracted Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. J Am Coll Cardiol (2011) 0.99
Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet (2002) 0.98
Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. Cytokine (2008) 0.98
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary. Circulation (2004) 0.98
Moxifloxacin and torsade de pointes. Ann Pharmacother (2007) 0.98
Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study. Arterioscler Thromb Vasc Biol (2007) 0.97
Effects of preoperative neuromuscular electrical stimulation on quadriceps strength and functional recovery in total knee arthroplasty. A pilot study. BMC Musculoskelet Disord (2010) 0.97
Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials. Prog Cardiovasc Dis (2005) 0.96
Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium. Am J Cardiol (2011) 0.96
Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review. Pharmacotherapy (2012) 0.96
Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther (2008) 0.95
Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open (2013) 0.94
Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother (2002) 0.94
INSIG2 gene polymorphism is associated with increased subcutaneous fat in women and poor response to resistance training in men. BMC Med Genet (2008) 0.94
Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2. Am Heart J (2009) 0.93
AKT1 polymorphisms are associated with risk for metabolic syndrome. Hum Genet (2011) 0.92
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria? J Womens Health (Larchmt) (2008) 0.92
Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. Metabolism (2010) 0.91
Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity. Med Sci Sports Exerc (2009) 0.91
The association among blood transfusions, white blood cell count, and the frequency of post-cardiothoracic surgery atrial fibrillation: a nested cohort study from the Atrial Fibrillation Suppression Trials I, II, and III. J Cardiothorac Vasc Anesth (2008) 0.90
Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET. J Clin Pharmacol (2005) 0.90
Differences in fat and muscle mass associated with a functional human polymorphism in a post-transcriptional BMP2 gene regulatory element. J Cell Biochem (2009) 0.89
Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord (2008) 0.89
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. J Am Coll Cardiol (2008) 0.89
CCL2 and CCR2 variants are associated with skeletal muscle strength and change in strength with resistance training. J Appl Physiol (1985) (2010) 0.88
Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. Am J Cardiol (2004) 0.88
A comparision of the hemostatic effects of notoginseng and yun nan bai yao to placebo control. J Herb Pharmacother (2005) 0.88
Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial. Cardiovasc Drugs Ther (2012) 0.88
Role of thrombotic and fibrinolytic factors in acute coronary syndromes. Prog Cardiovasc Dis (2004) 0.88
Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm (2006) 0.88
Effects of home-based resistance training and neuromuscular electrical stimulation in knee osteoarthritis: a randomized controlled trial. BMC Musculoskelet Disord (2012) 0.87